Category Archives: news

Multicentre randomised controlled trial confirms the significant benefits of Phagenyx® treatment for tracheostomised stroke patients with dysphagia

September 2018

Manchester, England, 4 September 2018–Phagenesis Ltd, a pioneering leader in the treatment of dysphagia, is pleased to announce today the publication of its most recent randomised controlled trial (PHAST-TRAC) in the journal Lancet Neurology read more. Reinhard Krickl, CEO of Phagenesis, said: “The … Continue reading

Posted in General updates, news | Comments Off on Multicentre randomised controlled trial confirms the significant benefits of Phagenyx® treatment for tracheostomised stroke patients with dysphagia

Patients with Parkinson’s disease needed for swallowing treatments study

August 2018

The University of Manchester in collaboration with Salford Royal Hospital is looking for patients from Greater Manchester with confirmed diagnosis of idiopathic Parkinson’s disease and impaired swallowing. They will be offered the possibility to participate in a clinical study that … Continue reading

Posted in General updates, news | Comments Off on Patients with Parkinson’s disease needed for swallowing treatments study

PhEED, a new RCT for post ischemic or hemorrhagic stoke patients with dysphagia has started enrollment in the US and Europe

May 2018

Pharyngeal Electrical Stimulation Evaluation for Dysphagia after Stroke (PhEED) is a prospective multi-centre randomised controlled single-blinded trial with Non-Significant Risk status granted by FDA. If you are a healthcare professional working in an acute rehab center and are interested in being part … Continue reading

Posted in General updates, news | Comments Off on PhEED, a new RCT for post ischemic or hemorrhagic stoke patients with dysphagia has started enrollment in the US and Europe

Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science

October 2017

Manchester, 4 October 2017 – Phagenesis announced today that by completing a key clinical study in Europe it has reached the first milestone in its staged acquisition agreement with Nestlé Health Science (NHSc). Under the terms of the agreement, Nestlé … Continue reading

Posted in General updates, news | Comments Off on Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science

The staged acquisition of Phagenesis by Nestlé Health Science will benefit patients with dysphagia

September 2016

Manchester, England, 1 September 2016 – Nestlé Health Science (NHSc) and Phagenesis announced today that NHSc is entering into a staged, milestone-based acquisition of Phagenesis, a medical device company that has developed a new treatment for dysphagia. Under the terms … Continue reading

Posted in news | Comments Off on The staged acquisition of Phagenesis by Nestlé Health Science will benefit patients with dysphagia

Healthy Volunteers needed for new products testing

September 2015

We are looking for healthy people interested in doing research to help us test our new devices for comfort and tolerability before we seek CE mark and launch them commercially. The study will involve a single 3-hour visit to our … Continue reading

Posted in news | Comments Off on Healthy Volunteers needed for new products testing